X-RAY DIFFRACTION

Crystallization Details
Method pH Temprature Details
X-RAY DIFFRACTION 8.5 288 Protein: 32.5 mg/mL in 20 mM Tris pH 8.0, 500 mM sodium chloride, 2 mM beta-mercaptoethanol, incubated with inhibitor (2.5 mM final concentration) overnight, Mixed 1:1 with crystallization solution (27-33% (v/v) Peg400, 200 mM magnesium chloride, 100 mM Tris pH 8.5), vapor diffusion, sitting drop, temperature 288K, VAPOR DIFFUSION, SITTING DROP
Unit Cell:
a: 50.924 Å b: 91.120 Å c: 69.699 Å α: 90.00° β: 99.81° γ: 90.00°
Symmetry:
Space Group: P 1 21 1
Crystal Properties:
Matthew's Coefficient: 2.18 Solvent Content: 43.68
Refinement Statistics
Diffraction ID Structure Solution Method Cross Validation Method Resolution Limit (High) Resolution Limit (Low) Number of Reflections (Observed) Number of Reflections (R-free) Percent Reflections (Observed) R-Work R-Free Mean Isotropic
X-RAY DIFFRACTION FOURIER SYNTHESIS ? 2.718 34.74 14204 1420 83.57 0.2483 0.2958 ?
Data Collection
Overall
Resolution Limit (High) Resolution Limit (Low) Percent Possible (Observed) R Merge I (Observed) R Sym I (Observed) Net I Over Average Sigma (I) Redundancy Number Reflections (All) Number Reflections (Observed) Observed Criterion Sigma (F) Observed Criterion Sigma (I) B (Isotropic) From Wilson Plot
2.71 34.74 97.5 0.110 ? 11.6 4.1 16507 16507 -3.0 -3.0 32.27
Highest Resolution Shell
# Resolution Limits (Low) Resolution Limits (High) Percent Possible (All) Percent Possible (Observed) R-Sym I (Observed) Mean I Over Sigma (Observed) Redundancy Number Unique Reflections (All)
1 2.71 2.73 100 ? ? 2.3 4.2 422
Diffraction
Diffraction experiment
Crystal ID Scattering Type Data Collection Temprature Detector Detector Type Details Collection Date Monochromator Protocol
1 100 K
Radiation Source
Source Type Wavelength List Synchrotron Site Beamline
SYNCHROTRON APS BEAMLINE 22-ID 0.97921 APS 22-ID
Software
Software Name Purpose Version
PHENIX model building .
PHENIX refinement (phenix.refine: dev_1439)
HKL-2000 data reduction .
HKL-2000 data scaling .
PHENIX phasing .